\
&
Contact us
\
&
Contact us
Published on | 1 hour ago
Programmes Agro-Food, EnvironmentThe European Commission, led by DG AGRI, is preparing a new EU Agricultural Research and Innovation (R&I) Strategic Approach, planned for mid-2026. This Strategic Approach aims to secure the long-term competitiveness, sustainability and resilience of the EU’s agri-food sector, forestry and rural areas, and contribute to the objectives of the Vision for Agriculture and Food and other Commission initiatives.
They invite interested persons to take part in a short questionnaire designed to gather feedback from key stakeholders across the agricultural, forestry, and rural sectors. You can access the survey here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Digital Europe AI Continent Cybersecurity
Flanders is pursuing an active industry and export policy focused on defence innovation. With the Flemish Innovation and Industry Strategy for Security and Defence (VISD) and a new weapon trading decree, the government plans to help local companies market their technologies internationally. The European defence and security market is rapidly expan... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
